186 related articles for article (PubMed ID: 23170982)
1. α-Tropomyosin with a D175N or E180G mutation in only one chain differs from tropomyosin with mutations in both chains.
Janco M; Kalyva A; Scellini B; Piroddi N; Tesi C; Poggesi C; Geeves MA
Biochemistry; 2012 Dec; 51(49):9880-90. PubMed ID: 23170982
[TBL] [Abstract][Full Text] [Related]
2. Effects of two familial hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin.
Kremneva E; Boussouf S; Nikolaeva O; Maytum R; Geeves MA; Levitsky DI
Biophys J; 2004 Dec; 87(6):3922-33. PubMed ID: 15454401
[TBL] [Abstract][Full Text] [Related]
3. Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin.
Ly S; Lehrer SS
Biochemistry; 2012 Aug; 51(32):6413-20. PubMed ID: 22794249
[TBL] [Abstract][Full Text] [Related]
4. The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy.
Li XE; Suphamungmee W; Janco M; Geeves MA; Marston SB; Fischer S; Lehman W
Biochem Biophys Res Commun; 2012 Aug; 424(3):493-6. PubMed ID: 22789852
[TBL] [Abstract][Full Text] [Related]
5. Effect of Cardiomyopathic Mutations in Tropomyosin on Calcium Regulation of the Actin-Myosin Interaction in Skeletal Muscle.
Kopylova GV; Shchepkin DV; Borovkov DI; Matyushenko AM
Bull Exp Biol Med; 2016 Nov; 162(1):42-44. PubMed ID: 27878731
[TBL] [Abstract][Full Text] [Related]
6. Several cardiomyopathy causing mutations on tropomyosin either destabilize the active state of actomyosin or alter the binding properties of tropomyosin.
Mathur MC; Chase PB; Chalovich JM
Biochem Biophys Res Commun; 2011 Mar; 406(1):74-8. PubMed ID: 21295541
[TBL] [Abstract][Full Text] [Related]
7. Facilitated cross-bridge interactions with thin filaments by familial hypertrophic cardiomyopathy mutations in α-tropomyosin.
Wang F; Brunet NM; Grubich JR; Bienkiewicz EA; Asbury TM; Compton LA; Mihajlović G; Miller VF; Chase PB
J Biomed Biotechnol; 2011; 2011():435271. PubMed ID: 22187526
[TBL] [Abstract][Full Text] [Related]
8. Effects of cardiomyopathic mutations on the biochemical and biophysical properties of the human alpha-tropomyosin.
Hilario E; da Silva SL; Ramos CH; Bertolini MC
Eur J Biochem; 2004 Oct; 271(20):4132-40. PubMed ID: 15479242
[TBL] [Abstract][Full Text] [Related]
9. Role of tropomyosin isoforms in the calcium sensitivity of striated muscle thin filaments.
Boussouf SE; Maytum R; Jaquet K; Geeves MA
J Muscle Res Cell Motil; 2007; 28(1):49-58. PubMed ID: 17436057
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in tropomyosin structure and function.
Janco M; Suphamungmee W; Li X; Lehman W; Lehrer SS; Geeves MA
J Muscle Res Cell Motil; 2013 Aug; 34(3-4):177-87. PubMed ID: 23832280
[TBL] [Abstract][Full Text] [Related]
11. Investigating the effects of tropomyosin mutations on its flexibility and interactions with filamentous actin using molecular dynamics simulation.
Zheng W; Hitchcock-DeGregori SE; Barua B
J Muscle Res Cell Motil; 2016 Oct; 37(4-5):131-147. PubMed ID: 27376658
[TBL] [Abstract][Full Text] [Related]
12. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.
Coutu P; Bennett CN; Favre EG; Day SM; Metzger JM
Circ Res; 2004 May; 94(9):1235-41. PubMed ID: 15059934
[TBL] [Abstract][Full Text] [Related]
13. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.
Michele DE; Gomez CA; Hong KE; Westfall MV; Metzger JM
Circ Res; 2002 Aug; 91(3):255-62. PubMed ID: 12169652
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyopathy-associated mutations in tropomyosin differently affect actin-myosin interaction at single-molecule and ensemble levels.
Kopylova GV; Shchepkin DV; Nabiev SR; Matyushenko AM; Koubassova NA; Levitsky DI; Bershitsky SY
J Muscle Res Cell Motil; 2019 Dec; 40(3-4):299-308. PubMed ID: 31643006
[TBL] [Abstract][Full Text] [Related]
15. Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations.
Bai F; Weis A; Takeda AK; Chase PB; Kawai M
Biophys J; 2011 Feb; 100(4):1014-23. PubMed ID: 21320446
[TBL] [Abstract][Full Text] [Related]
16. In vitro formation and characterization of the skeletal muscle α·β tropomyosin heterodimers.
Kalyva A; Schmidtmann A; Geeves MA
Biochemistry; 2012 Aug; 51(32):6388-99. PubMed ID: 22812662
[TBL] [Abstract][Full Text] [Related]
17. Thermal unfolding of homodimers and heterodimers of different skeletal-muscle isoforms of tropomyosin.
Matyushenko AM; Kleymenov SY; Susorov DS; Levitsky DI
Biophys Chem; 2018 Dec; 243():1-7. PubMed ID: 30265962
[TBL] [Abstract][Full Text] [Related]
18. Myopathic mutations in the β-chain of tropomyosin differently affect the structural and functional properties of ββ- and αβ-dimers.
Bershitsky SY; Logvinova DS; Shchepkin DV; Kopylova GV; Matyushenko AM
FASEB J; 2019 Feb; 33(2):1963-1971. PubMed ID: 30199282
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional properties of αβ-heterodimers of tropomyosin with myopathic mutations Q147P and K49del in the β-chain.
Matyushenko AM; Shchepkin DV; Susorov DS; Nefedova VV; Kopylova GV; Berg VY; Kleymenov SY; Levitsky DI
Biochem Biophys Res Commun; 2019 Jan; 508(3):934-939. PubMed ID: 30545627
[TBL] [Abstract][Full Text] [Related]
20. Structural and Functional Effects of Cardiomyopathy-Causing Mutations in the Troponin T-Binding Region of Cardiac Tropomyosin.
Matyushenko AM; Shchepkin DV; Kopylova GV; Popruga KE; Artemova NV; Pivovarova AV; Bershitsky SY; Levitsky DI
Biochemistry; 2017 Jan; 56(1):250-259. PubMed ID: 27983818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
